Abeona Therapeutics Inc (ABEO)

Abeona Therapeutics Inc (ABEO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $252M; returns 1 day -1.6%, 1 week -0.7%, 1 year -18.8%.

Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company primarily focused on developing and commercializing gene and cell therapies for rare, life-threatening genetic diseases.

Groups ABEO belongs to

• Rare Diseases
• Commercial Stage Biotech
• Gene Therapy
• Biopharmaceutical
• Autologous Cell Therapy
• Healthcare
• Biotechnology
• Life Sciences
• Dermatology
• Pharmaceuticals
• Ophthalmology

ABEO financial model: income statement, cash flow and balance sheet